General description
INN
Pembrolizumab
ATC codes
Medicine type
Biological agent
EML status history
Application rejected in 2019
(TRS
1021)
for
Other specified malignant neoplasms of bronchus or lung
Added in 2025
(TRS
1064)
for
Melanoma of skin
Added in 2025
(TRS
1064)
for
Other specified malignant neoplasms of large intestine
Added in 2025
(TRS
1064)
for
Malignant neoplasms of cervix uteri
Added in 2025
(TRS
1064)
for
Other specified malignant neoplasms of bronchus or lung
Application rejected in 2025
(TRS
1064)
for
Malignant neoplasms of oesophagogastric junction
Application rejected in 2025
(TRS
1064)
for
Adenocarcinoma of stomach
Application rejected in 2025
(TRS
1064)
for
Squamous cell carcinoma of other or ill-defined sites in the lip, oral cavity or pharynx
Application rejected in 2025
(TRS
1064)
for
Squamous cell carcinoma of oropharynx
Application rejected in 2025
(TRS
1064)
for
Squamous cell carcinoma of nasopharynx
Application rejected in 2025
(TRS
1064)
for
Squamous cell carcinoma of hypopharynx and variants
Application rejected in 2025
(TRS
1064)
for
Squamous cell carcinoma of oesophagus
Application rejected in 2025
(TRS
1064)
for
Renal cell carcinoma of kidney, except renal pelvis
Application rejected in 2025
(TRS
1064)
for
Carcinoma of breast, specialised type
Changed in 2025
(TRS
1064)
for
Melanoma of skin
Therapeutic equivalent for
Wikipedia
DrugBank
Recommendations
Section
Immunomodulators
- Parenteral > General injections > IV: 25 mg per mL in 4 mL vial powder for injection
- Parenteral > General injections > IV: 25 mg per mL in 4 mL vial
- Parenteral > General injections > IV: 25 mg per mL in 4 mL vial concentrate for solution for infusion
Indications
Other specified malignant neoplasms of bronchus or lung
Melanoma of skin
Malignant neoplasms of cervix uteri
Other specified malignant neoplasms of large intestine
Malignant neoplasms of oesophagogastric junction
Adenocarcinoma of stomach
Squamous cell carcinoma of other or ill-defined sites in the lip, oral cavity or pharynx
Squamous cell carcinoma of oropharynx
Squamous cell carcinoma of nasopharynx
Squamous cell carcinoma of hypopharynx and variants
Squamous cell carcinoma of oesophagus
Renal cell carcinoma of kidney, except renal pelvis
Carcinoma of breast, specialised type